New Deal
Julian Hudson
Managing Director at Rothschild & Co
Financial Advisor
London
Deal Bio
Awards
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (48)
Key Relationships
Announcement Date
Deal Value
SKYEPHARMA
Vectura Group
£407m
14 dealmakers
Corin Group
Investor Consortium
£35m
5 dealmakers
Envision Pharma
ARDIAN
value n/a
4 dealmakers
Idis Group Holdings
Clinigen Group
2 dealmakers
Db Ashbourne
ETHYPHARM
Amdipharm Mercury
Concordia Healthcare Corp
22 dealmakers
Sinclair Is Pharma's Non-aesthetics Business
Alliance Pharma Lc
Concept Life Sciences
Spectris
£163m
13 dealmakers
Eusa Pharma (critical Care Business)
Serb Pharmaceuticals (belgium)
Sinclair Pharma
Huadong Medicine Co
£179m
27 dealmakers
Btg
Boston Scientific Corporation
£3,029m
64 dealmakers
PELLEPHARM
Leo Pharma
£591m
8 dealmakers
Nestle Skin Health
Eqt Partners
£7,808m
196 dealmakers
Trimb Holding
Karo Pharma
£275m
54 dealmakers
Synpromics
ASKBIO
Bioclinica (clinical Research Site Business)
Pharmaceutical Product Development
24 dealmakers
Takeda Pharmaceutical Company (drug Portfolio)
Acino International
£159m
Riemser
ESTEVE
Covis Pharma
Apollo Global Management
91 dealmakers
Huntsworth
Clayton Dubilier & Rice
£524m
63 dealmakers
SYMPHOGEN
Servier International
30 dealmakers
Cello Health
Arsenal Capital Partners
£181m
31 dealmakers
Gho Capital Partners
36 dealmakers
Boston Scientific Corporation (btg Specialty Pharmaceuticals Business)
Charterhouse Capital Partners
£599m
43 dealmakers
Clario (ert)
Cinven
97 dealmakers
Cytel
Astorg Partners
Lucid Group
Intermediate Capital Group (icg)
29 dealmakers
NUTRAQ
Orkla Asa
£262m
11 dealmakers
Udg Healthcare
£2,777m
110 dealmakers
SYMERES
Keensight Capital
53 dealmakers
Philip Morris International
£1,025m
Hra Pharma
Perrigo Company
£1,515m
Abu Dhabi Development Corporation (adq)
7 dealmakers
BIOAGILYTIX
72 dealmakers
Eusa Pharma
Recordati
£638m
39 dealmakers
Clario (drug Safety Solutions Unit)
Stanley Capital Partners
19 dealmakers
Norgine
Goldman Sachs Asset Management
£1,533m
80 dealmakers
Open Health
£790m
25 dealmakers
UMOTIF
Athyrium Capital Management
£20m
6 dealmakers
Avania
Emmes Corporation
New Mountain Capital
£653m
Laboratoire X.o
9 dealmakers
The Binding Site Group
Thermo Fisher Scientific
£2,250m
47 dealmakers
INKE
£211m
20 dealmakers
DINAMIQS
Siegfried Holding
15 dealmakers
INSTEM
Archimed
£203m
Ergomed
Permira Advisers
£703m
45 dealmakers
Alcresta Therapeutics
Linden Capital Partners